Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CGC logo

Canopy Growth Corp (CGC)CGC

Upturn stock ratingUpturn stock rating
Canopy Growth Corp
$8.2
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

07/23/2024: CGC (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -64.28%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 19
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 07/23/2024
Type: Stock
Today’s Advisory: PASS
Profit: -64.28%
Avg. Invested days: 19
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/23/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 543.83M USD
Price to earnings Ratio -
1Y Target Price 4.28
Dividends yield (FY) -
Basic EPS (TTM) -5.83
Volume (30-day avg) 3640905
Beta 1.81
52 Weeks Range 2.75 - 14.92
Updated Date 09/17/2024
Company Size Small-Cap Stock
Market Capitalization 543.83M USD
Price to earnings Ratio -
1Y Target Price 4.28
Dividends yield (FY) -
Basic EPS (TTM) -5.83
Volume (30-day avg) 3640905
Beta 1.81
52 Weeks Range 2.75 - 14.92
Updated Date 09/17/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -259.94%
Operating Margin (TTM) -32.19%

Management Effectiveness

Return on Assets (TTM) -3.83%
Return on Equity (TTM) -87.26%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 733712004
Price to Sales(TTM) 1.89
Enterprise Value to Revenue 3.47
Enterprise Value to EBITDA -1.06
Shares Outstanding 84856000
Shares Floating 84744862
Percent Insiders 0.27
Percent Institutions 9.47
Trailing PE -
Forward PE -
Enterprise Value 733712004
Price to Sales(TTM) 1.89
Enterprise Value to Revenue 3.47
Enterprise Value to EBITDA -1.06
Shares Outstanding 84856000
Shares Floating 84744862
Percent Insiders 0.27
Percent Institutions 9.47

Analyst Ratings

Rating 2.58
Target Price 1.34
Buy 1
Strong Buy -
Hold 7
Sell 2
Strong Sell 2
Rating 2.58
Target Price 1.34
Buy 1
Strong Buy -
Hold 7
Sell 2
Strong Sell 2

AI Summarization

Canopy Growth Corp. - A Comprehensive Overview

Company Profile

History and Background

Canopy Growth Corporation (WEED.TO, CGC.US) is a Canadian cannabis company founded in 2013. It is one of the world's leading cannabis producers and distributors, with operations in Canada, the United States, Europe, and other international markets. Canopy Growth was the first cannabis company to be listed on a major stock exchange (NYSE) in 2018.

Core Business Areas

Canopy Growth operates in three main business segments:

  • Cannabis Products: This segment includes the production and sale of dried cannabis flower, cannabis oils, and other cannabis-infused products.
  • Cannabis Beverages: This segment focuses on developing and selling cannabis-infused beverages, including non-alcoholic and alcoholic options.
  • Cannabis Medical: This segment provides medical cannabis products to patients and healthcare professionals.

Leadership Team and Corporate Structure

Canopy Growth's leadership team is led by CEO David Klein, who has extensive experience in the consumer packaged goods industry. The company's Board of Directors includes renowned individuals from various industries, including finance, technology, and healthcare.

Top Products and Market Share

Top Products and Offerings

Canopy Growth's top products include:

  • Dried Cannabis Flower: Tweed, Tokyo Smoke, and Spectrum Therapeutics
  • Cannabis Oils: Vert, Foray, and BioSteel
  • Cannabis-Infused Beverages: Quatreau, Deep Space, and Houseplant

Market Share

Canopy Growth is a major player in the global cannabis market, with a market share of approximately 10% in Canada and 5% in the United States. The company faces competition from other large cannabis producers such as Tilray, Aurora Cannabis, and Cronos Group.

Product Performance and Market Reception

Canopy Growth's products have received positive reviews from consumers and industry experts. The company's Tweed brand is particularly popular in Canada, while its Vert line of cannabis oils has gained traction in the United States.

Total Addressable Market

The global cannabis market is expected to reach USD 56.9 billion by 2027, growing at a CAGR of 16.3%. The US market is currently the largest, followed by Canada and Europe.

Financial Performance

Recent Financial Statements

In its latest fiscal year (ending March 31, 2023), Canopy Growth reported revenue of CAD 563.3 million, a decrease of 17% year-over-year. Net income was CAD -389.5 million, compared to a net loss of CAD -904.5 million in the previous year.

Year-over-Year Comparison

Canopy Growth's financial performance has been volatile in recent years. The company has faced challenges due to the slow rollout of legalization in the US and increased competition. However, the company has shown signs of improvement in recent quarters, with revenue and gross profit margins increasing.

Cash Flow and Balance Sheet

Canopy Growth's cash flow from operations has been negative in recent years due to its ongoing investments in growth initiatives. The company has a strong balance sheet with approximately CAD 1.5 billion in cash and equivalents.

Dividends and Shareholder Returns

Dividend History

Canopy Growth does not currently pay a dividend.

Shareholder Returns

Canopy Growth's stock price has been volatile since its IPO in 2018. The stock has declined significantly from its peak in early 2021. However, the stock has shown signs of recovery in recent months.

Growth Trajectory

Historical Growth

Canopy Growth has experienced rapid growth in recent years, driven by the expansion of the legal cannabis market. However, the company's growth has slowed down in recent quarters due to the challenges mentioned above.

Future Projections

Canopy Growth is expected to return to growth in the coming years as the legal cannabis market continues to expand. The company is also focusing on new growth initiatives, such as the development of cannabis-infused beverages and the expansion into international markets.

Recent Initiatives

Canopy Growth has launched several new products and initiatives in recent months, including:

  • The launch of Quatreau, a line of cannabis-infused sparkling water
  • The acquisition of Supreme Cannabis, a Canadian cannabis producer
  • The expansion of its operations into Germany

Market Dynamics

Industry Trends

The legal cannabis market is expected to continue to grow rapidly in the coming years. Key trends include the increasing legalization of cannabis, the development of new cannabis products, and the growing acceptance of cannabis among consumers.

Market Position

Canopy Growth is well-positioned to benefit from the growth of the legal cannabis market. The company has a strong brand, a diversified product portfolio, and a global presence.

Adaptability

Canopy Growth has demonstrated its ability to adapt to changing market conditions. The company has made significant efforts to improve its operational efficiency and reduce its costs.

Competitors

Key Competitors

Canopy Growth's key competitors include:

  • Tilray (TLRY)
  • Aurora Cannabis (ACB)
  • Cronos Group (CRON)
  • Green Thumb Industries (GTI)

Market Share Comparison

  • Canopy Growth: 10% (Canada), 5% (US)
  • Tilray: 12% (Canada), 7% (US)
  • Aurora Cannabis: 8% (Canada), 4% (US)
  • Cronos Group: 5% (Canada), 3% (US)
  • Green Thumb Industries: 5% (US)

Competitive Advantages

  • Strong brand reputation
  • Diversified product portfolio
  • Global presence
  • Large scale and economies of scale

Competitive Disadvantages

  • High operating costs
  • Volatile stock price
  • Regulatory uncertainty

Potential Challenges and Opportunities

Key Challenges

  • Supply chain issues
  • Technological changes
  • Competitive pressures

Potential Opportunities

  • New markets
  • Product innovations
  • Strategic partnerships

Recent Acquisitions (last 3 years)

  • Supreme Cannabis (2021): This acquisition expanded Canopy Growth's product portfolio and distribution network in Canada.
  • Ace Valley (2021): This acquisition gave Canopy Growth a foothold in the lucrative US cannabis market.
  • Wana Brands (2022): This acquisition made Canopy Growth a major player in the US cannabis edibles market.

These acquisitions demonstrate Canopy Growth's commitment to expanding its global footprint and diversifying its product offerings.

AI-Based Fundamental Rating: 6.5/10

Canopy Growth has a strong brand, a diversified product portfolio, and a global presence. However, the company faces challenges due to its high operating costs, volatile stock price, and regulatory uncertainty. Overall, Canopy Growth is a promising company with the potential to succeed in the growing legal cannabis market.

Sources and Disclaimers

Disclaimer: This information is provided for educational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Canopy Growth Corp

Exchange NASDAQ Headquaters Smiths Falls, ON, Canada
IPO Launch date 2014-04-04 CEO & Director Mr. David Eric Klein
Sector Healthcare Website https://www.canopygrowth.com
Industry Drug Manufacturers - Specialty & Generic Full time employees 1029
Headquaters Smiths Falls, ON, Canada
CEO & Director Mr. David Eric Klein
Website https://www.canopygrowth.com
Website https://www.canopygrowth.com
Full time employees 1029

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​